Open Access

[Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways

  • Authors:
    • Kang Kang
    • Jing Zhang
    • Xiaoyun Zhang
    • Zhao Chen
  • View Affiliations

  • Published online on: January 23, 2023     https://doi.org/10.3892/or.2023.8488
  • Article Number: 51
  • Copyright : © Kang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

March-2023
Volume 49 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kang K, Zhang J, Zhang X and Chen Z: [Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways. Oncol Rep 49: 51, 2023
APA
Kang, K., Zhang, J., Zhang, X., & Chen, Z. (2023). [Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways. Oncology Reports, 49, 51. https://doi.org/10.3892/or.2023.8488
MLA
Kang, K., Zhang, J., Zhang, X., Chen, Z."[Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways". Oncology Reports 49.3 (2023): 51.
Chicago
Kang, K., Zhang, J., Zhang, X., Chen, Z."[Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways". Oncology Reports 49, no. 3 (2023): 51. https://doi.org/10.3892/or.2023.8488